By improving microcirculation to injured tissue, BPC-157 may support faster repair
Some of those who have used injectable peptides unapproved for US sale from unregulated suppliers on the gray market have reported concerns, including unwanted changes to skin pigmentation, infection, swelling, pain, redness, and new or changing moles. Addressing safety concerns, the APC CEO reports that there has not been an uptick in adverse events reported through the FDAs adverse events reporting database related to injectable peptides
Many clients report improved energy, focus, and overall mood after just a few treatments
For example, epidermal growth factor receptor (EGFR) inhibitors such as erlotinib and osimertinib disrupt epithelial homeostasis in the skin and gastrointestinal tract, resulting in acneiform rash, xerosis, and diarrhea